| 31° |
 |
Pictet-Biotech-HP EURLU0190161025 |
|
6.84%
(24°)
|
65.81%
(18°)
|
15.94%
(31°)
|
4.09%
(44°)
|
Open overview
and rankings |
| 32° |
|
Pictet-Biotech-R EURLU0255977539 |
|
5.99%
(39°)
|
63.90%
(30°)
|
15.48%
(32°)
|
6.49%
(37°)
|
Open overview
and rankings |
| 33° |
|
Pictet-Biotech-R USDLU0112497440 |
|
5.75%
(43°)
|
63.83%
(31°)
|
15.39%
(33°)
|
6.49%
(38°)
|
Open overview
and rankings |
| 34° |
|
Pictet-Biotech-HR EURLU0190162189 |
|
6.77%
(25°)
|
64.64%
(27°)
|
15.13%
(34°)
|
3.36%
(45°)
|
Open overview
and rankings |
| 35° |
 |
Candriam Equities L Biotechnology - C Part (R)LU0942225912 |
|
6.64%
(27°)
|
55.62%
(36°)
|
15.12%
(35°)
|
11.34%
(14°)
|
Open overview
and rankings |
| 36° |
|
Candriam Equities L Biotechnology - C Part (C)LU0108459040 |
|
6.61%
(28°)
|
60.54%
(34°)
|
15.11%
(36°)
|
9.73%
(21°)
|
Open overview
and rankings |
| 37° |
|
Candriam Equities L Biotechnology - C Part (R - GBP - Unhedged)LU1269736911 |
|
6.35%
(33°)
|
55.23%
(37°)
|
15.11%
(37°)
|
11.29%
(15°)
|
Open overview
and rankings |
| 38° |
|
Candriam Equities L Biotechnology - C Part (V)LU0317020203 |
|
6.40%
(31°)
|
54.04%
(39°)
|
14.45%
(38°)
|
10.65%
(16°)
|
Open overview
and rankings |
| 39° |
|
Candriam Equities L Biotechnology - C Part (I)LU0133360163 |
|
6.36%
(32°)
|
53.84%
(40°)
|
14.31%
(39°)
|
10.52%
(17°)
|
Open overview
and rankings |
| 40° |
|
Candriam Equities L Biotechnology - C Part (I - GBP - Unhedged)LU1269737059 |
|
6.11%
(36°)
|
53.42%
(43°)
|
14.30%
(40°)
|
10.24%
(19°)
|
Open overview
and rankings |
| 41° |
|
Candriam Equities L Biotechnology - C Part (I - EUR - Hedged)LU1006082199 |
|
6.91%
(22°)
|
53.68%
(42°)
|
14.12%
(41°)
|
7.36%
(33°)
|
Open overview
and rankings |
| 42° |
|
Candriam Equities L Biotechnology - D Part (C)LU0108459552 - Distribute dividends |
|
6.55%
(29°)
|
54.20%
(38°)
|
14.06%
(42°)
|
10.25%
(18°)
|
Open overview
and rankings |
| 43° |
|
Candriam Equities L Biotechnology - C Part (N)LU0133359157 |
|
6.53%
(30°)
|
53.71%
(41°)
|
13.69%
(43°)
|
9.96%
(20°)
|
Open overview
and rankings |
| 44° |
 |
UBS (Lux) Equity Fund - Biotech (USD) Q-accLU0400035332 |
|
4.34%
(45°)
|
48.84%
(45°)
|
8.60%
(44°)
|
5.24%
(41°)
|
Open overview
and rankings |
| 45° |
|
UBS (Lux) Equity Fund - Biotech (USD) P-accLU0069152568 |
|
4.70%
(44°)
|
53.22%
(44°)
|
8.27%
(45°)
|
4.62%
(43°)
|
Open overview
and rankings |
| 46° |
|
Pictet-Biotech-P EURLU0255977455 |
|
0.00%
(48°)
|
0.00%
(48°)
|
0.00%
(46°)
|
0.00%
(49°)
|
Open overview
and rankings |
| 47° |
 |
AXA FRAMLINGTON BIOTECH AXA Framlington Biotech R AccGB0031007254 |
|
3.58%
(47°)
|
35.00%
(47°)
|
0.00%
(47°)
|
0.00%
(46°)
|
Open overview
and rankings |
| 48° |
|
AXA FRAMLINGTON BIOTECH AXA Framlington Biotech Z AccGB00B784NS11 |
|
3.67%
(46°)
|
36.05%
(46°)
|
0.00%
(48°)
|
0.00%
(47°)
|
Open overview
and rankings |
| 49° |
|
Pictet Biotech HP CHFLU0843168732 |
|
0.00%
(49°)
|
0.00%
(49°)
|
0.00%
(49°)
|
0.00%
(48°)
|
Open overview
and rankings |
SpA. Click on the individual Funds and read the overview with the expected return and risk indicators.
